Maternal and neonatal outcomes following the introduction of oral hypoglycaemic agents for gestational diabetes mellitus were comparable to insulin monotherapy in two historical cohorts

Simple item page
dc.citation.doi10.7196/SAMJ.2020.V110I2.14024
dc.citation.epage158
dc.citation.spage154
dc.contributor.authorVeronique Nicolaou
dc.contributor.authorLarske Soepnel
dc.contributor.authorKenneth Huddle
dc.contributor.authorN Levitt
dc.contributor.authorKerstin Klipstein-Grobusch
dc.contributor.authorShane Norris
dc.date.accessioned2023-06-21T08:41:21Z
dc.date.available2023-06-21T08:41:21Z
dc.departmentInternal Medicine
dc.identifier.citationWOS
dc.identifier.issn0256-9574
dc.identifier.urihttps://hdl.handle.net/10539/35593
dc.journal.titleSAMJ SOUTH AFRICAN MEDICAL JOURNAL
dc.journal.volume110
dc.titleMaternal and neonatal outcomes following the introduction of oral hypoglycaemic agents for gestational diabetes mellitus were comparable to insulin monotherapy in two historical cohorts
Files
Collections
Research Outputs (Clinical Medicine)
Academic Wits Research Outputs (All submissions)